Drug Price Negotiation by the Inflation Reduction Act

The cost of medications is often attributed to a burden on healthcare - despite hospitalizations costing four times as much. Join host, Geoff Wall, as he discusses the new Inflation Reduction Act which allows the government to negotiate medication prices. The GameChangerThe US Federal Government can now negotiate with drug companies for the cost of medications. Similar to other countries, this bulk buying power can help lower medication prices for patients. HostGeoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint Health ReferenceHHS Selects the First Drugs for Medicare Drug Price Negotiationhttps://www.hhs.gov/about/news/2023/08/29/hhs-selects-the-first-drugs-for-medicare-drug-price-negotiation.html Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE Information Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. List the 10 medications first targeted by the new legislation for negotiation2. Describe the common arguments against this provision of the Inflation Reduction Act0.05 CEU/0.5 HrUAN: 0107-0000-23-321-H03-PInitial release date: 10/2/2023Expiration date: 10/2/2024Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram